The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Group Therapy for Primary Breast Cancer
Official Title: A Multicenter Trial of Group Therapy for Breast Cancer
Study ID: NCT00220792
Brief Summary: The purpose of this study is to determine whether women with primary breast cancer who were randomly assigned to receive a brief group therapy would show a greater reduction in mood disturbance over time compared to those randomized to the control condition. We also hypothesized that women who were highly distressed at baseline would show the greatest benefit from participating in a support group, and that therapists with more training and experience would be most effective in reducing distress.
Detailed Description: Breast cancer patients often experience significant psychological distress after diagnosis and during initial treatment. Group interventions for cancer patients have been shown to improve psychological adjustment. The tests of efficacy for these interventions have typically taken place in university settings using highly developed models of intervention. Our aim was to test our supportive-expressive model in community oncology practices utilizing personnel already working with these populations. To conduct this study of group therapy for primary breast cancer patients, we developed a brief version of the supportive-expressive model (Classen et al., 1993). Our first aim was to test the efficacy of this intervention for reducing mood disturbance for women who received the intervention compared to a control group. A second aim was to examine who was most likely to benefit from the intervention. A third aim was to see if this method could be taught efficiently and effectively to oncology nurses and mental health professionals.
Minimum Age: 0 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Social Work Consultants, Inc, Wichita, Kansas, United States
Kalamazoo Community Clinical Oncology Program, Kalamazoo, Michigan, United States
Metro-Minnesota CCOP, St. Louis Park, Minnesota, United States
Northern New Jersey CCOP, Hackensack, New Jersey, United States
North Shore University Hospital CCOP, Manhasset, New York, United States
University of Rochester CCOP, Rochester, New York, United States
Syracuse Hem/Onc CCOP, Syracuse, New York, United States
Northwest CCOP, Tacoma, Washington, United States
Marshfield Medical Research Foundation, Marshfield, Wisconsin, United States
Milwaukee CCOP, Milwaukee, Wisconsin, United States
Name: David Spiegel, MD
Affiliation: Stanford University
Role: PRINCIPAL_INVESTIGATOR